CorVel (CRVL) Form 4: 1,500-Option Grant to Director, 4-Year Vesting
Rhea-AI Filing Summary
Michael Jeffrey J, identified as a director and 10% owner of CorVel Corp (CRVL), was granted 1,500 non-qualified stock options on 08/07/2025 with an exercise price of $85.56. The options expire on 08/07/2035 and become exercisable in four equal annual installments beginning 12 months after the grant, so vesting begins on 08/07/2026. The Form 4 reports the reporting person directly beneficially owns 1,500 derivative securities following the transaction. The filing is signed on 08/11/2025.
Positive
- 1,500 non-qualified stock options granted to a director and 10% owner on 08/07/2025
- Clear vesting schedule: four equal annual installments commencing 12 months after grant; 10-year term to 08/07/2035
Negative
- None.
Insights
TL;DR: Routine director option grant: 1,500 options, $85.56 strike, 4-year vesting, 10-year term.
This Form 4 documents a standard non-qualified stock option grant to a director who is also a 10% owner. Key facts are the 1,500-option size, $85.56 exercise price, vesting in four equal annual installments starting 12 months after grant, and a 10-year expiration to 08/07/2035. The filing shows direct beneficial ownership of the 1,500 options following the grant. From a governance perspective, the disclosure is clear and follows required Section 16 reporting rules.
TL;DR: Typical equity-based compensation structure with multi-year vesting and long exercise window; no other compensation detail disclosed.
The grant is a non-qualified stock option with an explicit exercise price of $85.56 and a stated vesting schedule of four equal annual installments beginning 12 months post-grant. The instrument covers 1,500 shares and expires on 08/07/2035. The Form 4 does not provide additional compensation terms (such as performance conditions or forfeiture provisions), so assessment is limited to the shown mechanics of the award.